lobbying_activities: 1908242

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1908242	81d9d1bb-135d-4bd6-9133-e03133d46158	Q4	ADVANCED POLICY CONSULTING, LLC	401103524	PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)	2016	fourth_quarter	MMM	Opposition to the Center for Medicare and Medicaid Innovation's (CMMI) new Part B Drug model, which would put patient access and quality of care at risk.	HOUSE OF REPRESENTATIVES,SENATE	30000		0	0	2016-12-29T10:29:17.803000-05:00